SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Lindman B) "

Sökning: WFRF:(Lindman B)

  • Resultat 1-50 av 80
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • Wilking, N., et al. (författare)
  • Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy
  • 2007
  • Ingår i: Annals of Oncology. - : Elsevier BV. - 0923-7534 .- 1569-8041. ; 18:4, s. 694-700
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: The purpose was to investigate adjuvant marrow-supportive high-dose chemotherapy compared with an equitoxicity-tailored comparator arm. Patients and methods: Five hundred and twenty-five women below theage of 60 years with operated high-risk primary breast cancer were randomised to nine cycles of granulocyte colony-stimulating factor supported and individually tailored FEC (5-fluorouracil, epirubicin, cyclophosphamide), (n = 251) or standard FEC followed by marrow-supported high-dose therapy with CTCb (cyclophosphamide, thiotepa, carboplatin) therapy (n = 274), followed by locoregional radiotherapy and tamoxifen for 5 years. Results: There were 104 breast cancer relapses in the tailored FEC group versus 139 in the CTCb group (double triangular method by Whitehead, P = 0.046), with a median follow-up of all included patients of 60.8 months. The event-free survival demonstrated 121 and 150 events in the tailored FEC- and CTCb group, respectively [P = 0.074, hazard ratio (HR) 0.804, 95% confidence interval (CI) 0.633-1.022]. Ten patients in the tailored FEC regimen developed acute myeloid leukaemia (AML)/myelodysplasia (MDS). One hundred deaths occurred in the tailored FEC group and 121 in the CTCb group (P = 0.287, HR 0.866, 95% CI 0.665-1.129). Conclusion: The update of this study shows an improved outcome linked to the tailored FEC treatment in relation to breast cancer relapse, but also an increased incidence of AML/MDS. © 2007 Oxford University Press.
  •  
3.
  • Lindman, Henrik, et al. (författare)
  • A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1)
  • 2018
  • Ingår i: European Journal of Cancer. - : Elsevier BV. - 0959-8049 .- 1879-0852. ; 94, s. 79-86
  • Tidskriftsartikel (refereegranskat)abstract
    • Study aim: Retrospective studies have demonstrated a worse outcome in breast cancer patients not developing leukopenia during adjuvant chemotherapy. The SBG 2000-1 is the first randomised trial designed to compare individually dosed chemotherapy without G-CSF support based on grade of toxicity to standard-dosed chemotherapy based on body surface area (BSA). Methods: Patients with early breast cancer were included and received the first cycle of standard FEC (fluorouracil 600 mg/m2, epirubicin 60 mg/m2, cyclophosphamide 600 mg/m2). Patients with nadir leukopenia grade 0–2 after first cycle were randomised between either 6 additional courses of tailored FEC with increased doses (E 75–90 mg/m2, C 900–1200 mg/m2) or fixed treatment with 6 standard FEC. Patients with grade 3–4 leukopenia were registered and treated with 6 standard FEC. Primary end-point was distant disease-free survival (DDFS). Results: The study enrolled 1535 patients, of which 1052 patients were randomised to tailored FEC (N = 524) or standard FEC (N = 528), whereas 401 patients with leukopenia grade 3–4 continued standard FEC and formed the registered cohort. Dose escalation did not statistically significantly improve 10-year DDFS (79% and 77%, HR 0.87, CI 0.67–1.14, P = 0.32) or OS (82% and 78%, respectively, HR 0.89, CI 0.57–1.16, P = 0.38). Corresponding estimates for the registered group of patients were DDFS 79% and OS 82%, respectively. Conclusions: The SBG 2000-1 study failed to show a statistically significant improvement of escalated and tailored-dosed chemotherapy compared with standard BSA-based chemotherapy in patients with low haematological toxicity, although all efficacy parameters showed a numerical advantage for tailored treatment.
  •  
4.
  •  
5.
  • Andersson, J, et al. (författare)
  • A population-based study on the first forty-eight breast cancer patients receiving trastuzumab (Herceptin (R)) on a named patient basis in Sweden
  • 2002
  • Ingår i: Acta Oncologica. - : Informa UK Limited. - 1651-226X .- 0284-186X. ; 41:3, s. 276-281
  • Tidskriftsartikel (refereegranskat)abstract
    • Several studies have presented data on the efficacy and tolerability of trastuzumab within clinical trials. As a minority of patients is included in these trials, we undertook this retrospective study to describe trastuzumab therapy in clinical routine and its tolerability. We reviewed the medical records of the first 48 patients in Sweden who received treatment with trastuzumab on a named patient basis with (n = 29) and without (n = 19) chemotherapy. Forty-six patients had metastatic disease and had failed to respond to several prior regimens before starting antibody treatment. Two patients had locally advanced breast cancer failing on given neoadjuvant therapy. Patients with breast cancers with strong (3+) c-erbB-2 overexpression tended to have an improved survival from start of trastuzumab treatment versus those with a moderate (2+) overexpression (p=0.09). Adverse events were registered in 22 patients (46%). The most common and acute side effects were fever and chills (7 patients, 15%). The toxicity seemed reasonable but two patients (4%) suffered serious cardiac events, both of them having received previous treatment with antracyclines.
  •  
6.
  • Billsten, P, et al. (författare)
  • Adsorption of human carbonic anhydrase II onto silicon oxides surfaces : The effects of truncation in the N-terminal region
  • 1998
  • Ingår i: The Colloid Science of Lipids New Paradigms for Self-Assembly in Science and Technology. - 1435-1536 .- 0340-255X. - 9783798511125 - 9783798516557 ; 108, s. 161-165
  • Konferensbidrag (refereegranskat)abstract
    • The adsorption of human carbonic anhydrase II pseudo-wild type (HCAIIpwt) and an N-terminally truncated version thereof onto silica surfaces were studied. The amount adsorbed and the adsorption kinetics were measured using in situ ellipsometry. A substantial difference was seen between the two proteins. The adsorbed amount of the truncated version (2.53 mg/m2) indicates an end-on orientation, while the HCAIIpwt seems to adsorb side-on (1.84 mg/m2). It is suggested that the orientation effects arise from the truncation. The truncation is known to unfold the two most N-terminal helical segments, which could inhibit adsorption with the N-terminal region facing the surface, due to steric repulsion.
  •  
7.
  • Loman, N., et al. (författare)
  • Nordic trip, a randomized phase 3 study in early triple negative breast cancer
  • 2016
  • Ingår i: Cancer Research. - Lund Univ, Skane Univ Hosp, Lund, Sweden. Sahlgrens Acad, Gothenburg, Sweden. Univ Hosp, Gothenburg, Sweden. Univ Helsinki, Cent Hosp, Helsinki, Finland. Univ Helsinki, Helsinki, Finland. Rigshosp, DBCG Secretariat, DK-2100 Copenhagen, Denmark. Univ Hosp, Landspitali, Reykjavik, Iceland. Akershus Univ Hosp, Lorenskog, Norway. Orebro Univ Hosp, Orebro, Sweden. Uppsala Univ, Akad Hosp, Uppsala, Sweden.. - 0008-5472 .- 1538-7445. ; 76
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
  •  
8.
  • Medronho, B., et al. (författare)
  • Cyclodextrin-grafted cellulose: Physico-chemical characterization
  • 2013
  • Ingår i: Carbohydrate Polymers. - : Elsevier BV. - 0144-8617. ; 93:1, s. 324-330
  • Tidskriftsartikel (refereegranskat)abstract
    • Cyclodextrins (CDs) can form inclusion complexes with a wide variety of molecules making them very attractive in different areas, such as pharmaceutics, biochemistry, food chemistry and textile. In this communication we will report on the physico-chemical characterization of cellulose modified with CDs by means of infra-red spectroscopy (FTIR), cross polarization magic angle spinning solid state nuclear magnetic resonance (CP-MAS NMR), polarized optical microscopy (POM) and thermal gravimetric analysis (TGA). Both CP-MAS NMR and FTIR indicate that CDs are chemically attached to cellulose backbone through the formation of ester bonds. Furthermore, the CD-grafted cellulose was dissolved in a "superphosphoric" acid solution but, despite the increase of hydrophilicity due to the modification, POM revealed that grafted cellulose was less soluble when compared to the unmodified polymer. The formation of a complex CD-cellulose network is suggested.
  •  
9.
  •  
10.
  •  
11.
  • Alves, L., et al. (författare)
  • Unusual extraction and characterization of nanocrystalline cellulose from cellulose derivatives
  • 2015
  • Ingår i: Journal of Molecular Liquids. - : Elsevier BV. - 0167-7322 .- 1873-3166. ; 210, s. 106-112
  • Tidskriftsartikel (refereegranskat)abstract
    • Unlike many nanomaterials, nanocrystalline cellulose (CNC) is not synthesized from molecular or atomic components but rather extracted from naturally occurring cellulose. Undoubtedly, the exploitation of CNCs will become a bridge between nanoscience and natural resource products, which could play a major role in reviving the forest industry. In this work, CNC was successfully extracted from unusual sources, hydroxypropyl methylcellulose (HPMC) and carboxymethylcellulose (CMC). The extracted crystallites were purified and further characterized by Fourier transform infrared (FTIR), scanning electron microscopy (SEM), X-ray powder diffraction (XRD) and dynamic light scattering (DLS). The average size of the CNCs extracted from HPMC and CMC was found to be less (and with lower zeta potential) than the ones extracted from microcrystalline cellulose (MCC). On the other hand, FTIR and XRD revealed that native HPMC and CMC are unexpectedly highly crystalline and hence can be used as a source for CNCs. © 2014 Elsevier B.V.All rights reserved.
  •  
12.
  • Alvez, Maria Bueno, et al. (författare)
  • Next generation pan-cancer blood proteome profiling using proximity extension assay
  • 2023
  • Ingår i: Nature Communications. - : Springer Nature. - 2041-1723. ; 14:1
  • Tidskriftsartikel (refereegranskat)abstract
    • A comprehensive characterization of blood proteome profiles in cancer patients can contribute to a better understanding of the disease etiology, resulting in earlier diagnosis, risk stratification and better monitoring of the different cancer subtypes. Here, we describe the use of next generation protein profiling to explore the proteome signature in blood across patients representing many of the major cancer types. Plasma profiles of 1463 proteins from more than 1400 cancer patients are measured in minute amounts of blood collected at the time of diagnosis and before treatment. An open access Disease Blood Atlas resource allows the exploration of the individual protein profiles in blood collected from the individual cancer patients. We also present studies in which classification models based on machine learning have been used for the identification of a set of proteins associated with each of the analyzed cancers. The implication for cancer precision medicine of next generation plasma profiling is discussed.
  •  
13.
  • Antunes, FE, et al. (författare)
  • Ionization by pH and Anionic Surfactant Binding Gives the Same Thickening Effects of Crosslinked Polyacrylic Acid Derivatives
  • 2012
  • Ingår i: Journal of Dispersion Science and Technology. - : Informa UK Limited. - 0193-2691 .- 1532-2351. ; 33:9, s. 1368-1372
  • Tidskriftsartikel (refereegranskat)abstract
    • Physical properties of aqueous solutions of hydrophobically modified crosslinked polyacrylic acids change quite extensively as the polymer is charged up. A study is carried out concerning the similarities between two polymer ionization processes, that is, by pH increment and anionic surfactant addition. The two processes charge the polymer by distinctly different mechanisms. At sufficiently high pH the carboxylic groups of the polymer are virtually all ionized and the polymer is, therefore, fully charged. The effective repulsion among the charged groups due to the entropy of the counterions promotes an increased stiffness as well as an expansion of the polymer particles. We investigate here how the ionization and swelling will be if, instead of high pH, the polymer is at low pH conditions but associated to ionic surfactants. Surfactants associate to the polymer both in a noncooperative way by the binding of individual surfactant molecules and in a cooperative way as micelles since the polymer promotes surfactant self-assembly. This binding leads to a highly charged polymer-surfactant complex and leads to an osmotic swelling as well. The swelling and the gelation were monitored by rheology and dynamic light scattering, of polymer solutions by varying the pHs and adding ionic surfactants at low pH. The results show that ionization by surfactants and by pH lead to approximately the same gelation degree, as can be seen by similar viscosity values. Both processes result in dramatic viscosity increases, up to 8 orders of magnitude. More hydrophobic surfactants, with longer alkyl chain, are shown to be more efficient as enhancers of swelling and gelation. The network that is formed at high pH or at sufficiently high concentration of surfactant can be weakened or even disrupted if monovalent or divalent salts are added, demonstrating the role of counterion entropy.
  •  
14.
  •  
15.
  •  
16.
  • Bo, A D, et al. (författare)
  • Ethyl(hydroxyethyl)cellulose-sodium dodecanoate interaction investigated by surface tension and electrical conductivity techniques
  • 2005
  • Ingår i: Colloids and Surfaces A: Physicochemical and Engineering Aspects. - : Elsevier BV. - 0927-7757. ; 256:2-3, s. 171-180
  • Tidskriftsartikel (refereegranskat)abstract
    • Mixtures of ethyl (hydroxyethyl)cellulose (EHEC) and sodium dodecanoate (SDoD) were investigated using surface tension, conductivity and transmittance measurements. The parameters of the surfactant to polymer association processes such as the critical aggregation concentration (cac) and saturation of the polymer by SDoD (psp) were determined from the plots of surface tension and specific conductivity versus surfactant concentration. The transmittance versus [SDoD] profiles exhibited bands that, in conjunction with conductivity and surface tension data, gave support to the explanation of the behavior of EHEC-SDoD-water solutions. Transmittance bands determined in the presence of EHEC and surfactant are sensitive to the process of surfactant to polymer binding. In this process, a discontinuity point represented by a second broader peak in the transmittance plots was identified, implying a slight inhibition of the breakdown of the network process. This is explained as a kind of intermediate re-structural network of the complexes produced by the formation of regular SDoD micelles. It was demonstrated that the second conductivity breakpoint marks the polymer saturation by surfactant clusters, and the effect of the EHEC concentration on the process of binding can be described by a linear correlation when the psp breakpoint is plotted against the polymer concentration. (c) 2005 Elsevier B.V. All rights reserved.
  •  
17.
  •  
18.
  • Claesson, PM, et al. (författare)
  • Forces between hydrophobic surfaces coated with ethyl(hydroxyethyl)cellulose in the presence of an ionic surfactant
  • 1991
  • Ingår i: Langmuir. - 0743-7463 .- 1520-5827. ; 7, s. 1441-1446
  • Tidskriftsartikel (refereegranskat)abstract
    • The forces between hydrophobic surfaces across an aqueous solution containing 0.25% ethyl(hydroxyethyl)cellulose (EHEC) and 4 mM SDS have been studied and compared with the situation in the absence of SDS. A long-range repulsive force (measurable at distances smaller than 1200 Å) is present already after an adsorption time of 30 minutes. The range of the repulsive force increases with time indicating that the adsorption process is rather slow. After 20 hours equilibration, the repulsion was measurable at separations smaller than 2500 Å. The force is rather insensitive to temperature and decays at large separations essentially exponentially, with a decay-length of approximately 300 Å. The force measured on compression is always slightly larger than the one observed on decompression. Hence, the forces are not measured in a true equilibrium situation. The system behaves strikingly different in the absence of SDS (Malmsten and Claesson, Langmuir, in press). Without any surfactant in the EHEC solution less long-range and completely reversible forces are observed. Hence, SDS causes the polymer conformation to be more extended, and is responsible for the non-equilibrium effects observed (e.g. by decreasing the polymer-surface affinity). The adsorbed amount in the presence of SDS was found to be about 1.7 mg/m2 at adsorption equilibrium, independent of temperature (20°-35°C). This is considerably less than in the absence of surfactants (5 mg/m2 at 20°C, 15 mg/m2 at 37°C).
  •  
19.
  •  
20.
  •  
21.
  • Despotou, George, et al. (författare)
  • Localisation, Personalisation and Delivery of Best Practice Guidelines on an Integrated Care and Cure Cloud Architecture : The C3-Cloud Approach to Managing Multimorbidity
  • 2020
  • Ingår i: Digital Personalized Health and Medicine. - : IOS Press. - 9781643680835 - 9781643680828 ; , s. 623-627
  • Konferensbidrag (refereegranskat)abstract
    • BACKGROUND: C3-Cloud is an integrated care ICT infrastructure offering seamless patient-centered approach to managing multimorbidity, deployed in three European pilot sites. Challenge: The digital delivery of best practice guidelines unified for multimorbidity, customized to local practice, offering the capability to improve patient personalization and benefit.METHOD: C3-Cloud has adopted a co-production approach to developing unified multimorbidity guidelines, by collating and reconciling best practice guidelines for each condition. Clinical and technical teams at pilot sites and the C3-Cloud consortium worked in tandem to create the specification and technical implementation.RESULTS: C3-Cloud offers CDSS for diabetes, renal failure, depression and congenital heart failure, with over 300 rules and checks that deliver four best practice guidelines in parallel, customized for each pilot site.CONCLUSIONS: The process provided a traceable, maintainable and audited digitally delivered collated and reconciled guidelines.
  •  
22.
  • Dias, Rita, et al. (författare)
  • Electrophoretic properties of complexes between DNA and the cationic surfactant cetyltrimethylammonium bromide
  • 2005
  • Ingår i: Electrophoresis. - : Wiley. - 0173-0835 .- 1522-2683. ; 26:15, s. 2908-2917
  • Tidskriftsartikel (refereegranskat)abstract
    • We use agarose gel electrophoresis to characterize how the monovalent catioinic surfactant cetyltrimethylammonium bromide (CTAB) compacts double-stranded DNA, which is detected as a reduction in electrophoretic DNA velocity. The velocity reaches a plateau at a ratio R = 1.8 of CTAB to DNA-phosphate charges, i.e., above the neutralization point, and the complexes retain a net negative charge at least up to R = 200. Condensation experiments on a mixture of two DNA sizes show that the complexes formed contain only one condensed DNA molecule each. These CTAB-DNA globules were further characterized by time-resolved measurements of their velocity inside the gel, which showed that CTAB does not dissociate during the migration but possibly upon entry into the gel. Using the Ogston-model for electrophoresis of spherical particles, the measured in-gel velocity of the globule is quantitatively consistent with CTAB having two opposite effects, reduction of both the electrophoretic charge and DNA coll size. In the case of CTAB the two effects nearly cancel, which can explain why opposite velocity shifts (globule faster than uncomplexed DNA) have been observed with some catioinic condensation agents. Dissociation of the complexes by addition of anionic surfactants was also studied. The DNA release from the globule was complete at a mixing ratio between anionic and cationic surfactants equal to 1, in agreement with equilibrium studies. Circular DNA retained its supercoiling, and this demonstrates a lack of DNA nicking in the compaction-release cycle which is important in DNA transfection and purification applications.
  •  
23.
  • Edlund, Per, et al. (författare)
  • Dose-tailoring of FEC adjuvant chemotherapy based on leukopenia is feasible and well tolerated. Toxicity and dose intensity in the Scandinavian Breast Group phase 3 adjuvant Trial SBG 2000-1
  • 2011
  • Ingår i: Acta Oncologica. - : Informa Healthcare. - 0284-186X .- 1651-226X. ; 50:3, s. 329-337
  • Tidskriftsartikel (refereegranskat)abstract
    • The SBG 2000-1 trial is a randomised study that investigates if dose-tailored adjuvant FEC therapy based on the individual's leukocyte nadir value can improve outcome. The study has included 1535 women with medium and high-risk breast cancer. Patients and methods. After a first standard dosed FEC course (5-fluorouracil 600 mg/m(2), epirubicin 60 mg/mg(2) and cyclophosphamide 600 mg/m(2)), patients who did not reach leukopenia grade III or IV were randomised to standard doses (group standard) or doses tailored to achieve grade III leukopenia (group tailored) at courses 2 7. Patients who achieved leukopenia grade III or more after the first course were not randomised but continued on standard doses (group registered). Results. Both planned and actually delivered number of courses (seven) were the same in all three arms. The relative dose intensity was increased by a factor of 1.31 (E 1.22, C 1.43) for patients in the tailored arm compared to the expected on standard dose. Ninety percent of the patients in the tailored arm achieved leukopenia grade III-IV compared with 29% among patients randomised to standard dosed therapy. Dose tailoring was associated with acceptable acute non-haematological toxicity with more total alopecia, nausea, vomiting and fatigue. Conclusion. Dose tailoring according to leukopenia was feasible. It led to an increased dose intensity and was associated with acceptable excess of acute non-haematological toxicity.
  •  
24.
  • Erturkmen, Gokce B. Laleci, et al. (författare)
  • A Collaborative Platform for Management of Chronic Diseases via Guideline-Driven Individualized Care Plans
  • 2019
  • Ingår i: Computational and Structural Biotechnology Journal. - : Elsevier. - 2001-0370. ; 17, s. 869-885
  • Tidskriftsartikel (refereegranskat)abstract
    • Older center dot age is associated with an increased accumulation of multiple chronic conditions. The clinical management of patients suffering from multiple chronic conditions is very complex, disconnected and time-consuming with the traditional care settings. Integrated care is a means to address the growing demand for improved patient experience and health outcomes of multimorbid and long-term care patients. Care planning is a prevalent approach of integrated care, where the aim is to deliver more personalized and targeted care creating shared care plans by dearly articulating the role of each provider and patient in the care process. In this paper, we present a method and corresponding implementation of a semi-automatic care plan management tool, integrated with clinical decision support services which can seamlessly access and assess the electronic health records (EHRs) of the patient in comparison with evidence based clinical guidelines to suggest personalized recommendations for goals and interventions to be added to the individualized care plans. We also report the results of usability studies carried out in four pilot sites by patients and clinicians.
  •  
25.
  • Eskilsson, K, et al. (författare)
  • DNA-surfactant complexes at solid surfaces
  • 2001
  • Ingår i: Langmuir. - 0743-7463 .- 1520-5827. ; 17, s. 1666-1669
  • Tidskriftsartikel (refereegranskat)abstract
    • In this work, we report on the adsorption of complexes between DNA of different molecular weight and a cationic surfactant, cetyltrimethylammonium bromide (CTAB), on hydrophobized and hydrophilic negatively charged silica surfaces as measured by ellipsometry. We will demonstrate how the adsorption is affected by the state of the DNA-surfactant complexes formed in bulk solution. High molecular weight DNA molecules, which condense (transform from coil to globule state) on addition of small amounts of cationic surfactants, do not adsorb on hydrophilic silica prior to phase separation. However, DNA-surfactant complexes formed from low molecular weight DNA were found to adsorb. For these complexes surfactants interact with DNA, without condensation of the DNA. Adsorbed DNA-surfactant complexes can easily be removed from the hydrophilic silica surface when replacing the bulk DNA-surfactant solution with pure salt solution. At the hydrophobic surface the DNA adsorbs without addition of cationic surfactant. However, with addition of a very low amount of surfactant, a rapid increase in adsorbed amount and a simultaneous decrease in adsorbed layer thickness are observed. This compaction of the adsorbed layer is to some extent reversible when replacing the bulk DNA-surfactant solution with pure salt solution.
  •  
26.
  •  
27.
  •  
28.
  • Généreux, Philippe, et al. (författare)
  • Design and Rationale of the Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients with AsYmptomatic Severe Aortic Stenosis: The EARLY TAVR Trial.
  • 2024
  • Ingår i: American heart journal. - 1097-6744. ; 268, s. 94-103
  • Tidskriftsartikel (refereegranskat)abstract
    • For patients with asymptomatic, severe aortic stenosis (AS) and preserved left ventricular ejection fraction, current guidelines recommend clinical surveillance every 6 to 12 months. To date, no randomized trials have examined whether an early intervention with transcatheter aortic valve replacement (TAVR) will improve outcomes among these patients.EARLY TAVR is a prospective, randomized, controlled, multicenter trial, with an event-based design. Asymptomatic severe AS patients (n=900) are randomized 1:1 to either clinical surveillance or TAVR with the Edwards SAPIEN 3/SAPIEN 3 Ultra transcatheter heart valve. Patients are stratified by whether they are able to perform a treadmill stress test. The primary endpoint is death, stroke, or unplanned cardiovascular hospitalization. Patients who are asymptomatic but have a positive stress test will be followed in a registry and undergo aortic valve replacement as per current guidelines.EARLY TAVR is the largest randomized trial to date assessing the role of early intervention among patients with asymptomatic severe AS compared to clinical surveillance, and the first to study the role of TAVR.NCT03042104.
  •  
29.
  • Généreux, Philippe, et al. (författare)
  • Evolution and Prognostic Impact of Cardiac Damage After Aortic Valve Replacement.
  • 2022
  • Ingår i: Journal of the American College of Cardiology. - 1558-3597.
  • Tidskriftsartikel (refereegranskat)abstract
    • The impact of aortic valve replacement (AVR) on progression/regression of extra-valvular cardiac damage and its association with subsequent prognosis is unknown.To describe evolution of cardiac damage post-AVR and its association with outcomes.Patients undergoing transcatheter or surgical AVR from the PARTNER 2 and 3 trials were pooled and classified by cardiac damage stage at baseline and 1-year (Stage 0, no damage; Stage 1, left ventricular damage; Stage 2, left atrial or mitral valve damage; Stage 3, pulmonary vasculature or tricuspid valve damage; Stage 4, right ventricular damage). Proportional hazards models determined association between change in cardiac damage post-AVR and 2-year outcomes.Among 1974 patients, 121 (6.1%) were Stage 0, 287 (14.5%) Stage 1, 1014 (51.4%) Stage 2, 412 (20.9%) Stage 3, and 140 (7.1%) Stage 4 pre-AVR. Two-year mortality was associated with extent of cardiac damage at baseline and 1-year. Compared with baseline, cardiac damage improved in ∼15%, remained unchanged in ∼60%, and worsened in ∼25% of patients at 1-year. One-year change in cardiac damage stage was independently associated with mortality (adjHR for improvement=0.49; no change=1.0; worsening=1.95; p=0.023) and composite of death or heart failure hospitalization (adjHR for improvement=0.60; no change=1.0; worsening=2.25; p<0.001) at 2 years.In patients undergoing AVR, extent of extravalvular cardiac damage at baseline and its change at 1-year have important prognostic implications. These findings suggest that earlier detection of AS and intervention prior to development of irreversible cardiac damage may improve global cardiac function and prognosis.
  •  
30.
  • Gonçalves, Rui A., et al. (författare)
  • Elucidating the effect of additives on the alkyl chain packing of a double tail cationic surfactant
  • 2018
  • Ingår i: Journal of Colloid and Interface Science. - : Elsevier BV. - 0021-9797. ; 528, s. 400-409
  • Tidskriftsartikel (refereegranskat)abstract
    • Hypothesis: Some low molecular weight additives can strongly influence the phase behavior of aqueous surfactant systems, and this offers an important handle to control the properties of surfactant solutions and thus to optimize the stability and performance of various formulations. Experiments: The surfactant dioctadecyldimethylammonium chloride (DODAC) self-assembles into two lamellar phases in water, the gel phase (Lβ) and the liquid crystalline phase (Lα). Here, we present approaches to tune the gel-to-liquid crystalline transition temperature (Tm) with the use of additives. The effects of urea, sodium butyrate and butyric acid on the packing behavior of DODAC were determined. The surfactant phases were characterized using polarized optical microscopy (POM), differential scanning calorimetry (DSC), and small/wide angle X-ray scattering (SWAXS). Findings: All three additives - urea, sodium butyrate and butyric acid yield a single and stable lamellar phase. Urea and sodium butyrate have only minor effects on Tm, butyric acid gives a large decrease as it stabilizes the Lα phase with respect to the Lβ phase. From the bilayer thickness of the gel phase an interdigitated or tilted packing of the surfactant molecules is suggested. The addition of sodium butyrate gives a highly interdigitated gel structure and resulted in the transition from lamellar liquid crystal to an isotropic L3 phase.
  •  
31.
  • Hahn, Rebecca T, et al. (författare)
  • Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints.
  • 2023
  • Ingår i: Journal of the American College of Cardiology. - 1558-3597.
  • Tidskriftsartikel (refereegranskat)abstract
    • Interest in the pathophysiology, etiology, management, and outcomes of patients with tricuspid regurgitation (TR) has grown in the wake of multiple natural history studies showing progressively worse outcomes associated with increasing TR severity, even after adjusting for multiple comorbidities. Historically, isolated tricuspid valve surgery has been associated with high in-hospital mortality rates, leading to the development of transcatheter treatment options. The aim of this first Tricuspid Valve Academic Research Consortium document is to standardize definitions of disease etiology and severity, as well as endpoints for trials that aim to address the gaps in our knowledge related to identification and management of patients with TR. Standardizing endpoints for trials should provide consistency and enable meaningful comparisons between clinical trials. A second Tricuspid Valve Academic Research Consortium document will focus on further defining trial endpoints and will discuss trial design options.
  •  
32.
  • Hahn, Rebecca T, et al. (författare)
  • Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints.
  • 2023
  • Ingår i: The Annals of thoracic surgery. - 1552-6259.
  • Tidskriftsartikel (refereegranskat)abstract
    • Interest in the pathophysiology, etiology, management, and outcomes of patients with tricuspid regurgitation (TR) has grown in the wake of multiple natural history studies showing progressively worse outcomes associated with increasing TR severity, even after adjusting for multiple comorbidities. Historically, isolated tricuspid valve surgery has been associated with high in-hospital mortality rates, leading to the development of transcatheter treatment options. The aim of this first Tricuspid Valve Academic Research Consortium document is to standardize definitions of disease etiology and severity, as well as endpoints for trials that aim to address the gaps in our knowledge related to identification and management of patients with TR. Standardizing endpoints for trials should provide consistency and enable meaningful comparisons between clinical trials. A second Tricuspid Valve Academic Research Consortium document will focus on further defining trial endpoints and will discuss trial design options.
  •  
33.
  • Hahn, Rebecca T, et al. (författare)
  • Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints.
  • 2023
  • Ingår i: European heart journal. - 1522-9645.
  • Tidskriftsartikel (refereegranskat)abstract
    • Interest in the pathophysiology, etiology, management, and outcomes of patients with tricuspid regurgitation (TR) has grown in the wake of multiple natural history studies showing progressively worse outcomes associated with increasing TR severity, even after adjusting for multiple comorbidities. Historically, isolated tricuspid valve surgery has been associated with high in-hospital mortality rates, leading to the development of transcatheter treatment options. The aim of this first Tricuspid Valve Academic Research Consortium document is to standardize definitions of disease etiology and severity, as well as endpoints for trials that aim to address the gaps in our knowledge related to identification and management of patients with TR. Standardizing endpoints for trials should provide consistency and enable meaningful comparisons between clinical trials. A second Tricuspid Valve Academic Research Consortium document will focus on further defining trial endpoints and will discuss trial design options.
  •  
34.
  •  
35.
  • Hansson, P, et al. (författare)
  • Surfactant-polymer interactions
  • 1996
  • Ingår i: CURRENT OPINION IN COLLOID & INTERFACE SCIENCE. - : CURRENT SCIENCE LTD. ; 1:5, s. 604-613
  • Recension (övrigt vetenskapligt/konstnärligt)abstract
    • Whereas mixed solutions of a homopolymer and a surfactant show interesting analogies with mixed polymer solutions; it has been demonstrated recently that mixtures of hydrophobically modified water-soluble polymers and surfactants show analogies with mixed
  •  
36.
  •  
37.
  • Isheden, G., et al. (författare)
  • SWEDISH NATIONWIDE REGISTER DATA AS A LOW-COST RESOURCE TO DETECT DRUG-REPURPOSING SIGNALS : A STUDY ON DE NOVO METASTATIC BREAST CANCER PATIENTS
  • 2022
  • Ingår i: Value in Health. - : Elsevier. - 1098-3015 .- 1524-4733. ; 25:12 Suppl., s. S375-S375
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
    • Objectives: Electronic health records have recently been highlighted as a low-cost resource to accelerate cancer therapeutics by drug repurposing discovery (Wu et al., JCO Clinical Cancer Informatics 2019:3, 1-9). The aim of this study was to test this approach on Swedish nationwide register data focusing on breast cancer cases with distant metastasis at initial diagnosis (de novo mBC). To demonstrate the feasibility of this methodology we i) evaluated the nine drug candidates identified by Wu et al. on our dataset, ii) generated drug repurposing hypotheses based on prescription drugs given to patients during metastatic breast cancer diagnosis/treatment.Methods: Patients diagnosed with de novo mBC between 2010 and 2020 were identified in the Swedish Cancer Register. Data on prescription drug use was collected from the National Prescribed Drug Register and survival data was collected from the National Cause of Death Register. Based on a 6-month window from diagnosis, drug repurposing candidates were evaluated using Cox proportional hazards models.Results: A total of 2,106 de novo mBC patients were included. The nine drug candidates found by Wu et al. (Rosuvastatin, Simvastatin, Amlodipine, Tamsulosin, Metformin, Omeprazole, Warfarin, Lisinoprol and Metroprolol) were not found significant in our data. However, a total of seven other drug repurposing hy-potheses were generated, with a plausible biological rationale for at least five of them (Calcium + Vitamin D, Morphine, Furosemide, Salbutamol and Ipratropium bromide, and Fentanyl). The other two were vaginal gel and Fluoride mouthwash.Conclusions: This study shows that the Swedish National Health Data Registers may be leveraged as a low-cost data source to detect drug repurposing signals. While results need to be interpreted with caution to not confuse causal relationships, the hypotheses generated in our study show a model for discovering noncancer drug effects on overall survival.
  •  
38.
  • Jausovec, D., et al. (författare)
  • Enzymatic Degradation of Model Cellulose Film Pre-Treated with Antimicrobial Agent
  • 2009
  • Ingår i: Journal of Dispersion Science and Technology. - : Informa UK Limited. - 0193-2691 .- 1532-2351. ; 30:6, s. 929-936
  • Tidskriftsartikel (refereegranskat)abstract
    • Enzymatic degradation of model cellulose films pre-treated with antimicrobial agent, 3-(trimethoxysilyl)-propyldimethyloctadecyl ammonium chloride (TMPAC) was investigated. AFM topographical imaging was used to assess the surface morphology, roughness, and thickness of the dried and hydrated model cellulose film. The kinetics of the model cellulose film in the hydrated state, the adsorption of TMPAC onto the film followed by desorption given by an enzyme extracted from Trichoderma Viride were studied by in situ null ellipsometry. The results show that the adsorption of TMPAC onto model cellulose film slows down the rate of degradation, as confirmed by a slower decrease in the film mass and by different behaviour of the thickness of the film pre-treated with antimicrobial agent in comparison with pure model cellulose film.
  •  
39.
  • Jausovec, D., et al. (författare)
  • The antimicrobial reagent role on the degradation of model cellulose film
  • 2008
  • Ingår i: Journal of Colloid and Interface Science. - : Elsevier BV. - 1095-7103 .- 0021-9797. ; 327:1, s. 75-83
  • Tidskriftsartikel (refereegranskat)abstract
    • The effect of the antimicrobial agent TMPAC (3-(trimethoxysilyl)-propyldimethyloctadecyl ammonium chloride) on the cellulase activity oil model cellulose substrate was investigated by in situ-null ellipsometry. The cellulases used were extracted from Trichoderma virlde and Aspergillus niger, and the model cellulose film was prepared by spin-coating silicon oxide wafers with cellulose solubilized in N-methylmorpholine-N-oxide/dimethyl sulfoxide solution. Upon enzyme addition to the previously equilibrated cellulose film, the initial enzyme adsorption oil the substrate was followed by an overall decrease in film mass owing to enzymatic digestion of the cellulose. The loss of cellulose film mass was associated with a non-monotonously behavior of the cellulose film thickness. The activities of the two enzymes were different, a much higher degradation rate being observed for the Trichoderma viride cellulase. The degradation rate with this cellulase decreased significantly when the cellulose film was treated with the antimicrobial agent. The antimicrobial agent did not affect the cellulose degradation catalyzed by the Aspergillus niger cellulase. It was, hence, demonstrated for the first time that, depending on the cellulase type, the antimicrobial agent can inhibit enzymatic activity at the solid-liquid interface. (C) 2008 Published by Elsevier Inc.
  •  
40.
  • Jespersen, S., et al. (författare)
  • HIV treatment in Guinea-Bissau : room for improvement and time for new treatment options
  • 2020
  • Ingår i: AIDS Research and Therapy. - : Springer Science and Business Media LLC. - 1742-6405. ; 17:1
  • Forskningsöversikt (refereegranskat)abstract
    • Despite advances in the treatment quality of HIV throughout the world, several countries are still facing numerous obstacles in delivering HIV treatment at a sufficiently high quality, putting patients' lives in jeopardy. The aim of this status article is to give an overview of HIV treatment outcomes in the West African country, Guinea-Bissau, and to assess how newer treatment strategies such as long-acting injectable drugs or an HIV cure may limit or stop the HIV epidemic in this politically unstable and low-resource setting. Several HIV cohorts in Guinea-Bissau have been established and are used as platforms for epidemiological, virological, immunological and clinical studies often with a special focus on HIV-2, which is prevalent in the country. The Bandim Health Project, a demographic surveillance site, has performed epidemiological HIV surveys since 1987 among an urban population in the capital Bissau. The Police cohort, an occupational cohort of police officers, has enabled analyses of persons seroconverting with estimated times of seroconversion among HIV-1 and HIV-2-infected individuals, allowing incidence measurements while the Bissau HIV Cohort and a newer Nationwide HIV Cohort have provided clinical data on large numbers of HIV-infected patients. The HIV cohorts in Guinea-Bissau are unique platforms for research and represent real life in many African countries. Poor adherence, lack of HIV viral load measurements, inadequate laboratory facilities, high rates of loss to follow-up, mortality, treatment failure and resistance development, are just some of the challenges faced putting the goal of "90-90-90″ for Guinea-Bissau well out of reach by 2020. Maintaining undetectable viral loads on treatment as a prerequisite of a cure strategy seems not possible at the moment. Thinking beyond one-pill-once-a-day, long-acting antiretroviral treatment options such as injectable drugs or implants may be a better treatment option in settings like Guinea-Bissau and may even pave the way for an HIV cure. If the delivery of antiretroviral treatment in sub-Saharan Africa in a sustainable way for the future should be improved by focusing on existing treatment options or through focusing on new treatment options remains to be determined.
  •  
41.
  •  
42.
  •  
43.
  • Kjallquist, U., et al. (författare)
  • Real World Evaluation of the Prosigna/PAM50 Test in a Node-Negative Postmenopausal Swedish Population: A Multicenter Study
  • 2022
  • Ingår i: Cancers. - : MDPI AG. - 2072-6694. ; 14:11
  • Tidskriftsartikel (refereegranskat)abstract
    • Gene expression signatures can provide important information on the risk of recurrence in patients with hormone receptor positive early breast cancer, and they can guide post-operative treatment. We have investigated how the implementation of gene-expression-based risk signatures with the Prosigna((R)) test impacted patient management in Sweden. The two major conclusions of this study are that prognostic factors derived from routine pathology were poor predictors of the intrinsic subtype and the risk of recurrence score, and that gene-expression-based risk combined with clinicopathological biomarkers (tumor size, Ki67, tumor grade) spared patients from adjuvant chemotherapy, but also identified patients who would potentially benefit from this treatment. Molecular signatures to guide decisions for adjuvant chemotherapy are recommended in early ER-positive, HER2-negative breast cancer. The objective of this study was to assess what impact gene-expression-based risk testing has had following its recommendation by Swedish national guidelines. Postmenopausal women with ER-positive, HER2-negative and node negative breast cancer at intermediate clinical risk and eligible for chemotherapy were identified retrospectively from five Swedish hospitals. Tumor characteristics, results from Prosigna((R)) test and final treatment decision were available for all patients. Treatment recommendations were compared with the last version of regional guidelines before the introduction of routine risk signature testing. Among the 360 included patients, 41% (n = 148) had a change in decision for adjuvant treatment based on Prosigna((R)) test result. Out of the patients with clinical indication for adjuvant chemotherapy, 52% (n = 118) could avoid treatment based on results from Prosigna((R)) test. On the contrary, 23% (n = 30) of the patients with no indication were escalated to receive adjuvant chemotherapy after testing. Ki67 could not distinguish between the Prosigna((R)) risk groups or intrinsic subtypes and did not significantly differ between patients in which decision for adjuvant therapy was changed based on the test results. In conclusion, we report the first real-world data from implementation of gene-expression-based risk assessment in a Swedish context, which may facilitate the optimization of future versions of the national guidelines.
  •  
44.
  •  
45.
  • Kronberg, Bengt, et al. (författare)
  • Surface Chemistry of Surfactants and Polymers
  • 2014
  • Bok (övrigt vetenskapligt/konstnärligt)abstract
    • © 2014 John Wiley & Sons, Ltd. All rights reserved. This book gives the reader an introduction to the field of surfactants in solution as well as polymers in solution. Starting with an introduction to surfactants the book then discusses their environmental and health aspects. Chapter 3 looks at fundamental forces in surface and colloid chemistry. Chapter 4 covers self-assembly and 5 phase diagrams. Chapter 6 reviews advanced self-assembly while chapter 7 looks at complex behaviour. Chapters 8 to 10 cover polymer adsorption at solid surfaces, polymers in solution and surface active polymers, respectively. Chapters 11 and 12 discuss adsorption and surface and interfacial tension, while Chapters 13- 16 deal with mixed surfactant systems. Chapter 17, 18 and 19 address microemulsions, colloidal stability and the rheology of polymer and surfactant solutions. Wetting and wetting agents, hydrophobization and hydrophobizing agents, solid dispersions, surfactant assemblies, foaming, emulsions and emulsifiers and microemulsions for soil and oil removal complete the coverage in chapters 20-25.
  •  
46.
  •  
47.
  • Larsson, Britt, et al. (författare)
  • Fibre type proportion and fibre size in trapezius muscle biopsies from cleaners with and without myalgia and its correlation with ragged red fibres, cytochrome-c-oxidase-negative fibres, biomechanical output, perception of fatigue, and surface electromyography during repetitive forward flexions
  • 2001
  • Ingår i: European Journal of Applied Physiology. - : Springer Science and Business Media LLC. - 1439-6327 .- 1439-6319. ; 84:6, s. 492-502
  • Tidskriftsartikel (refereegranskat)abstract
    • In the literature enlarged/increased cross-sectional area (CSA) of type I muscle fibres has been reported as a morphological mark of work-related localised myalgia in the descending part of the trapezius muscle of women. These studies did not use enough subjects or lacked an adequate control group. The recording of surface electromyograms (EMG) is central to the research field of work-related myalgia. However, the influence of intrinsic muscle properties such as the effect of muscle fibre distribution upon surface EMG has to be better understood in order properly to evaluate this method as a possible diagnostic and preventive tool. This study had two aims. Firstly, it investigated the muscle fibre distribution and CSA in work-related myalgia in trapezius muscles. Secondly, the multivariate relationships among muscle morphology and histochemistry [ragged-red (RR) fibres, and cytochrome-c-oxidase-negative-fibre changes] EMG, perceived fatigue, and biomechanical output of shoulder flexions were analysed. The raw data have been presented in an earlier study. The participants in this study were 25 female cleaners with work-related myalgia of the trapezius muscle and 25 female cleaners not experiencing work-related myalgia of this muscle. The control group comprised 21 healthy female teachers who had not been exposed to highly repetitive work or static muscle work. Smaller CSA of type II fibres were found in cleaners compared to teachers. In this study the CSA of type I fibres of the trapezius muscles associated with myalgia were no greater than in muscles without myalgia. The prevalence of RR fibres together with age, fibre type proportions, CSA and working as a cleaner correlated with the ability to relax as recorded electromyographically. The relative mean frequency of the EMG of the trapezius muscle correlated with the prevalence of RR fibres, but it did not correlate with the proportions and CSA of different fibre types. Low biomechanical outputs and low signal amplitude increases of the EMG during the test were associated with high proportions of type -IIB fibres. The smaller CSA of type II fibres in cleaners might have reflected a different muscle activation pattern due to different occupational demands in cleaners than in teachers. Morphological or histopathological variables can influence the three EMG variables investigated.
  •  
48.
  •  
49.
  •  
50.
  • Lindman, Björn, et al. (författare)
  • Colloidal systems in DNA packaging
  • 2003
  • Ingår i: Meeting on Self-Assembly - the Future. - 1586033824 ; , s. 374-386
  • Konferensbidrag (refereegranskat)abstract
    • The interaction between DNA and cationic cosolutes- multivalent ions, cationic surfactants and cationic macromolecules- has direct biological implications and is also foreseen to have a number of applications, in particular for transfection and protection and purification of DNA. We have during the last few years established a broad physico-chemical research program on various mixed systems of DNA and cationic surfactants. This collaborative Lund-Coimbra project will be outlined, reporting recent findings as well as research plans. The research is largely based on our previous work on mixed polymer-surfactant systems and as a basis we will describe some important general features of those.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-50 av 80
Typ av publikation
tidskriftsartikel (57)
konferensbidrag (14)
bokkapitel (3)
samlingsverk (redaktörskap) (2)
bok (2)
forskningsöversikt (1)
visa fler...
recension (1)
visa färre...
Typ av innehåll
refereegranskat (64)
övrigt vetenskapligt/konstnärligt (16)
Författare/redaktör
Lindman, Björn (19)
Lindman, H (15)
Bergh, J (11)
Blomqvist, C (6)
Lindman, Henrik (6)
Medronho, B. (6)
visa fler...
Redfors, Björn (5)
Cohen, David J (5)
Ahlgren, J (5)
Lidbrink, E (5)
Andersson, Roland (4)
Ejlertsen, B (4)
Ljungman, P (4)
Axelsson, Jakob B (4)
Tingstedt, Bobby (4)
Nehez, Laszlo (4)
Norgren, Magnus, 196 ... (4)
Costa, Carolina (4)
Wilking, N (4)
Hansson, P. (3)
Nilsson, J. (3)
Malmström, Per (3)
Soderberg, M (3)
Erikstein, B (3)
Malmstrom, P (3)
Romano, A (3)
Malmsten, M (3)
Windecker, Stephan (3)
Baron, Suzanne J (3)
Acs, B (3)
Hartman, J (3)
Fredriksson, I (3)
Badano, Luigi (3)
Lurz, Philipp (3)
Sannino, Anna (3)
Villman, K (3)
Leipsic, Jonathon (3)
Ben-Yehuda, Ori (3)
Norrgren, Hans (3)
Dias, Rita (3)
Anderson, H (3)
Fornander, T (3)
Karlsson, P (3)
Vemulapalli, Sreekan ... (3)
Linderholm, B (3)
Holte, H (3)
Alves, L. (3)
Wist, E (3)
Miguel, Maria (3)
Wiklund, T (3)
visa färre...
Lärosäte
Lunds universitet (28)
Karolinska Institutet (22)
Uppsala universitet (15)
Göteborgs universitet (11)
RISE (9)
Mittuniversitetet (7)
visa fler...
Chalmers tekniska högskola (7)
Umeå universitet (5)
Örebro universitet (3)
Linköpings universitet (3)
Kungliga Tekniska Högskolan (1)
Karlstads universitet (1)
visa färre...
Språk
Engelska (80)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (31)
Naturvetenskap (18)
Teknik (11)
Samhällsvetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy